Skip to Content
Merck
CN
  • Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.

Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.

Biochimica et biophysica acta (1998-09-28)
Y Pommier, P Pourquier, Y Fan, D Strumberg
ABSTRACT

DNA topoisomerase I is essential for cellular metabolism and survival. It is also the target of a novel class of anticancer drugs active against previously refractory solid tumors, the camptothecins. The present review describes the topoisomerase I catalytic mechanisms with particular emphasis on the cleavage complex that represents the enzyme's catalytic intermediate and the site of action for camptothecins. Roles of topoisomerase I in DNA replication, transcription and recombination are also reviewed. Because of the importance of topoisomerase I as a chemotherapeutic target, we review the mechanisms of action of camptothecins and the other topoisomerase I inhibitors identified to date.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(S)-(+)-Camptothecin, ≥90% (HPLC), powder